Treatment of colorectal carcinoma with antisense...

Details Treatment of colorectal carcinoma with antisense... Treatment of colorectal carcinoma with antisense...

A - Human Necessities

61

K

A61K 31/70 (2006.01) C07K 14/82 (2006.01) C12N 15/11 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2109829

2109829 9220348 PCTABS00017 Colorectal carcinoma is treated by administering oligonucleotides having a nucleotide sequence complementary to at least a portion of the mRNA transcript of the human c-myb gene. These "antisense" oligonucleotides are hybridizable to the c-myb mRNA transcript.

Affiliated with

Also associated with

Rating

Treatment of colorectal carcinoma with antisense... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of colorectal carcinoma with antisense..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of colorectal carcinoma with antisense... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2080144